Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs 819.55, up by 5.25 points or 0.64% from its previous closing of Rs 814.30 on the BSE.

The scrip opened at Rs. 822.00 and has touched a high and low of Rs. 823.20 and Rs. 812.40 respectively. So far 105530 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.70 on 07-Apr-2015 and a 52 week low of Rs. 743.25 on 08-Aug-2014.

Last one week high and low of the scrip stood at Rs. 839.90 and Rs. 810.05 respectively. The current market cap of the company is Rs. 197043.90 crore.

The promoters holding in the company stood at 54.71% while Institutions and Non-Institutions held 31.51% and 13.78% respectively

Sun Pharmaceutical Industries is reportedly likely to file application for a new drug with the US Food and Drug Administration (USFDA) in next two to three years. The company's research arm Sun Pharma Advanced Research Company (SPARC) is currently working on three new drugs that are currently under clinical trial stage.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.